FAS and neoplasm: To investigate whether we could further enhance FAS levels on the tumor cells, we combined the KDM1A inhibitor treatment with low-dose irradiation (2 Gy), but the combination therapy did not induce higher FAS expression levels than KDM1A inhibitor treatment alone (Figure 2C).